| Dr Michael N Moustakakis, MD | |
|
701 Cottage Grove Rd, Suite B220, Bloomfield, CT 06002-3080 | |
| (860) 769-9866 | |
| (860) 769-7300 |
| Full Name | Dr Michael N Moustakakis |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Nephrology |
| Location | 701 Cottage Grove Rd, Bloomfield, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275530685 | NPI | - | NPPES |
| 001367350 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 036735 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael N Moustakakis, MD 35 Jolley Dr, Suite 203, Bloomfield, CT 06002-3062 Ph: (860) 769-9866 | Dr Michael N Moustakakis, MD 701 Cottage Grove Rd, Suite B220, Bloomfield, CT 06002-3080 Ph: (860) 769-9866 |
News Archive
Solid-pseudopapillary neoplasm (SPN) of the pancreas is relatively rare. There are some similarities between SPN and pancreatic endocrine tumor (PET), especially the non-functioning ones, in clinical and pathological manifestations.
SATAI (www.satai.us) and the South Texas Regional Center of Innovation and Commercialization (www.strcic.com) today announced an investment of $1.045 million in Azaya Therapeutics, Inc. through the Texas Emerging Technology Fund (ETF) for the commercialization of Azaya's proprietary Protein Stabilized Nanoparticle (PSN) technology platform to produce targeted, safer and more effective formulations of chemotherapy pharmaceuticals for the treatment of cancer.
UPM researchers are involved in a European network to develop an endoscopic scanner for early detection of certain types of cancers that have a high mortality rate today.
After 7 days of recovery from a 10-day period of deficient sleep, participants in a small study had recovered their pre-sleep deprivation reaction speed, but had not fully recovered on any other measures of function.
Could engineered human stem cells hold the key to cancer survival? Scientists at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, have discovered that neural stem cells possess the innate ability to target tumor cells outside the central nervous system. This finding, which was demonstrated successfully on breast cancer cells, was recently published in leading peer reviewed journal, Stem Cells.
› Verified 7 days ago
Richard Siahaan, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 421 Cottage Grove Rd, Bloomfield, CT 06002 Phone: 860-242-0034 Fax: 860-242-3301 | |
Tracy E Patel, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 711 Cottage Grove Rd, Bloomfield, CT 06002 Phone: 860-242-8756 Fax: 860-242-3052 | |
Dr. Roy A Kellerman, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 35 Jolley Dr Ste 201, Bloomfield, CT 06002 Phone: 860-243-5569 Fax: 860-243-2622 | |
Arthur Bernard Landry Jr., M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 711 Cottage Grove Rd, Cottage Grove Cardiology, Bloomfield, CT 06002 Phone: 860-242-8756 Fax: 860-769-5009 | |
Dr. Linda Rickman, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 852 Cottage Grove Rd, Bloomfield, CT 06002 Phone: 860-714-5895 Fax: 860-714-5417 | |
Oksana Kloyzner, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 701 Cottage Grove Rd, Suite F, Bloomfield, CT 06002 Phone: 860-242-4000 Fax: 860-243-8286 | |
Usama Bin Nasir, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 711 Cottage Grove Rd, Bloomfield, CT 06002 Phone: 860-242-8756 |